Home › Chronic Lymphocytic Leukemia › NCT04028531

Understanding Chronic Lymphocytic Leukemia

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
* Any low grade lymphoproliferative disorder
* Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere

Exclusion Criteria:

\-

About the study

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.

Sponsor: Dana-Farber Cancer Institute · Participants: 2,750 · Started: Sep 29, 1999

Contact the study team

• Jennifer Brown, MD, PhD · Phone: 617-582-8437

Official record on ClinicalTrials.gov — NCT04028531

Locations in the U.S.

Conditions

• Chronic Lymphocytic Leukemia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.